Noval, Elora Thanna B.

HRN: 26-20-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2024
CEFUROXIME 750MG (VIAL)
11/14/2024
11/15/2024
IV
750
Q8
SP LTCS
Rejected 
11/14/2024
CEFUROXIME 500MG (TAB)
11/14/2024
11/20/2024
PO
500 Mg Tab
BID
Sp Ltcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: